- Bio-Path (NASDAQ:BPTH) on Thursday announced that it entered into a definitive agreement with certain institutional investors for the issuance and sale of 375,000 shares at $3.225/share in a registered direct offering priced at-the-market.
- Additionally, in a concurrent private placement, Bio-Path also agreed to issue to such investors unregistered warrants to purchase up to 375,000 shares at an exercise price of $3.10 per share.
- The gross proceeds from the offering are expected to be about $1.2 million, which Bio-Path intends to use towards working capital and general corporate purposes.
- Source: Press Release